Search Results

1 - 10 of 2,925 items :

  • "cardiovascular" x
Clear All
Primary prevention strategy for cardiovascular disease in Lithuania
(“A Funding Programme for the Screening and Preventive Management of the High Cardiovascular Risk Individuals” – main results: 2006–2017 years)

References [1] Health Information Centre, Institute of Hygiene, Ministry of Health of The Republic of Lithuania, Causes of death 2017, Vilnius 2018. . [2] WHO HFA Mortality database, 2009. [3] Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on

Open access
Review: The choice and cardiovascular safety of particular nonsteroidal anti-inflammatory drugs

, Shukla PK, Kaur P, Sharma S, Singh TP. Current perspectives in NSAID-induced gastropathy. Mediat Inflamm 2013;2013. [9] Bhala N, Emberson J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet 2013;382(9894):769-779. [10] Bello AE, Holt RJ. Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implications. Drug Safety 2014;37(11):897. [11] Perazella MA, Luciano RL. Review of select

Open access
Nuclear Transcription Factor Kappa B (NF-кB) and Molecular Damage Mechanisms in Acute Cardiovascular Diseases. A Review

REFERENCES 1. Mitropoulos FA, Odim J, Marelli D, et al. Outcome of hearts with cold ischemic time greater than 300 minutes. A casematched study. Eur J Cardiothorac Surg. 2005;28:143-148. doi: 10.1016/j.ejcts.2005.01.067. 2. Tonkin AM, Blankenberg S, Kirby A, et al. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study. Int J Cardiol. 2015;201:499-507. doi: 10.1016/j.ijcard.2015.07.080. 3. Vella RK, Pullen C, Coulson FR, Fenning AS. Resveratrol Prevents Cardiovascular Complications in the

Open access
Rationale of screening for early kidney damage in patients with high cardiovascular risk: nephrologist’s point of view

, Bonora E, Orsi E, Zerbini G, Giorgino F et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) study formula in subjects with type 2 diabetes. Atherosclerosis 2011; 218:194-199. [22] Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ et al. Current issues in measurementand reporting of urinary albumin excretion. Clin Chem 2009; 55:24-38. [23] MillerWG, Bruns DE

Open access
Serum ghrelin level is associated with cardiovascular risk score

REFERENCES 1. GARCÍA EA, KORBONITS M. Ghrelin and cardiovascular health. Curr Opin Pharmacol. 2006; 6 (2):142-7. 2. TESAURO M, SCHINZARI F, CARAMANTI M, LAURO R, CARDILLO C. Metabolic and cardiovascular effects of ghrelin. Int J Pept. 2010; 6 :62-70. 3. BROGLIO F, PRODAM F, ME E, RIGANTI F, LUCATELLO B, GRANATA R, BENSO A, MUCCIOLI G, GHIGO E. Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest. 2005; 28 (5 Suppl):23-5. 4. The Lipid Research Clinics Coronary Primary Prevention Trial Results I. Reduction

Open access
Cardiovascular Risk in Subclinical Hypothyroidism

Endocrinol 2011;165:115–121. 5. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. EndocrinolMetab (Seoul) 2014;29:20–29. 6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534. 7. Kim TH, Choi HS, Bae JC, Moon JH, Kim HK, Choi SH, et al. Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study. Eur J Endocrinol 2014;171:649-657. 8. Vanderpump MP, Tunbridge WM, French JM

Open access
Cardiovascular Disorders of Turner's Syndrome: A Review

, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 361(12): 1152-1163. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care. 1998; 21(7): 1062-1070. Kopacek Zilz C, Keller Brenner J, Elnecave RH. Portal vein thrombosis and high factor VIII in Turner syndrome. Horm Res. 2006

Open access
Correlations Between Acute Ischemic Stroke And Its Associated Cardiovascular Diseases

References 1. Georgieva Zh. Cardiovascular biomarkers. Sofia: Arbilis OOD; 2012. Bulgarian. 2. Malinska V, Vasileva E, Klisurski M, Muradian N, Partenov G, Genchev G, et al. Ischemic stroke in very old – risk factors and etiopathogenesis. Bulgarian Neurology. 2012;12(1):27-30. 3. Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, Liu SY, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med. 2014;25(6):538-44. 4. Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption

Open access
Fostering diffusion of scientific contents of National Society Cardiovascular Journals: the new ESC search engine

References [1] Alfonso F, Ambrosio G, Pinto FJ et al. European National Society cardiovascular journals. Background, rationale and mission statement of the “Editors’ Club” (Task Force of the European Society of Cardiology). Heart 2008; 94:e19. [2] Alfonso F, Ambrosio G, Pinto FJ et al. Editors’ Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the ‘editors’ network’. Eur Heart J 2010; 31:26-8. [3] Alfonso F, Timmis A, Pinto FJ et al. Editors’ Network European

Open access
Illicit drugs and their impact on cardiovascular pathology

REFERENCES 1. 2. WILBERT-LAMPEN U, SELIGER C, ZILKER T, ARENDT RM. Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine: Reversal by Coincubation With σ-Receptor Antagonists . Circulation 1998, 98 (5):385-390. 3. MO W, SINGH AK, ARRUDA JAL, DUNEA G. Role of Nitric Oxide in Cocaine-Induced Acute Hypertension . American Journal of Hypertension 1998, 11 (6):708-714. 4. LANGE RA, HILLIS LD. Cardiovascular Complications of Cocaine Use . New England

Open access